Figures
Abstract
Background
Previous studies of neuromyelitis optica spectrum disorder (NMOSD) using spectral domain optical coherence tomography (SD-OCT) showed that the outer nuclear layer (ONL) in eyes without a history of optic neuritis (ON) was thinner than that of healthy controls. It remains unclear whether the ONL thinning is caused by a direct attack on the retina by an autoantibody or a retrograde degeneration.
Methods
SD-OCT was used to determine the thicknesses of the different retinal layers of 21 eyes of 12 NMOSD patients without prior ON and 19 eyes of 10 healthy controls. Eyes with peripapillary retinal nerve fiber layer (RNFL) thinning were excluded to eliminate the confounding effects of retrograde degeneration. Microperimetry was used to determine the central retinal sensitivity. The data of the two groups were compared using generalized estimated equation models to account for inter-eye dependencies.
Results
The ganglion cell plus inner plexiform layer and the inner nuclear layer plus outer plexiform layer thicknesses of the NMOSD eyes were not significantly different from that of the control eyes (P = 0.28, P = 0.78). However, the ONL and average macular thickness (AMT) in the NMOSD eyes were significantly thinner than that of the control eyes (P = 0.022, P = 0.036). The retinal sensitivity in the central 10°, 10° to 2°, and 2° sectors were significantly lower in the NMOSD eyes than in the control eyes (P = 0.013, P = 0.022, P = 0.002).
Citation: Akiba R, Yokouchi H, Mori M, Oshitari T, Baba T, Sawai S, et al. (2016) Retinal Morphology and Sensitivity Are Primarily Impaired in Eyes with Neuromyelitis Optica Spectrum Disorder (NMOSD). PLoS ONE 11(12): e0167473. https://doi.org/10.1371/journal.pone.0167473
Editor: Rong Wen, University of Miami, UNITED STATES
Received: February 22, 2016; Accepted: November 15, 2016; Published: December 9, 2016
Copyright: © 2016 Akiba et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability: All relevant data are within the paper and its Supporting Information files.
Funding: The authors received no specific funding for this work.
Competing interests: The authors have declared that no competing interests exist.
Abbreviations: AMT, average macular thickness; NMOSD, neuromyelitis optica spectrum disorder; ON, optic neuritis; ONL, outer retinal layer; RNFL, retinal nerve fiber layer; SD-OCT, spectral-domain optical coherence tomography
Introduction
Neuromyelitis optica (NMO) is an inflammatory autoimmune disease that is associated with severe optic neuritis (ON) and/or longitudinally extensive transverse myelitis (LETM).[1] The discovery of immunoglobulin G (NMO-IgG)[2]/anti-aquaporin 4 (AQP4)[3] antibody has broadened the spectrum of NMO to neuromyelitis optica spectrum disorders (NMOSD).[4]
Optical coherence tomography (OCT) has been used to evaluate the retinal structures in neurogenerative diseases including multiple sclerosis (MS)[5] and NMOSD[6]. Previous studies have reported that the thickness of the peripapillary retinal nerve fiber layer (RNFL) was reduced in MS patients with history of optic neuritis (ON)[5]. It has also been reported that the peripapillary RNFL thickness is reduced in MS patients even with no history of ON[7, 8]. The subclinical changes of the retinal morphology are presented as either unrecognized subclinical optic neuritis or primary retinal pathology.
In NMOSD, Merle et al reported a thinning of the peripapillary RNFL in NMO patients with ON episodes [9] which has been confirmed by two other studies. [6, 10] Interestingly, Merle et al also reported a thinning of the peripapillary RNFL in NMO patients without prior ON history, and the changes were suggested to be due to chronic axonal injuries.[9] Outteryck et al also reported a thinning of the peripapillary RNLF thinning in NMOSD patients without a history of ON, and they hypothesized a retrograde transsynaptic degeneration as the cause of the pathology for subclinical RNFL thinning.[11] Additionally, a thinning of the macular RNFL[12] and ganglion cell and inner nuclear cell layer (GCIP)[13] in patients with NMOSD without a history of ON has been reported. These reports are consistent with previous studies suggesting a subclinical involvement of the anterior visual pathway possibly causing retrograde degeneration. On the other hand, several studies did not find a peripapillary RNFL thinning[10, 14–16], and thus the results of the different studies are contradictory.
Other OCT studies reported a significant thinning of the outer nuclear layer (ONL) in NMOSD patients without prior history of ON.[13, 17] Two causes for the ONL thinning have been proposed; one is that the thinning is due to a primary anti-AQP4-mediated retinal pathology directed against retinal astrocytes,[17] and the second cause is that it is due to retrograde degeneration.[13] These two hypotheses are contradictory, and there has not been sufficient evidence to support either hypothesis.
Parks et al reported that the ONL is thicker in patients with NMOSD than in healthy controls, and Schneider et al reported that the outer retinal layer including the ONL was not significantly different from that of healthy controls. [15, 18] These contradictory findings indicated that the morphological characteristics of NMOSD patient without prior optic neuritis have not been definitively determined.
To evaluate whether there is a primary retinal pathology independent of ON in NMOSD patients, we focused on patients without a prior history of ON. We also excluded eyes with peripapillary RNFL thinning to eliminate the confounding effects of retrograde degeneration. Earlier studies have reported subclinical changes of visual functions.[13, 19] We used macular integrity assessment (MAIA) to evaluate the visual function. We evaluated the morphological and retinal sensitivity changes in eyes with NMOSD without prior optic neuritis and peripapillary RNFL thinning.
Materials and Methods
Standard protocol approval, registration, and patient consent
The study was approved by Ethics Committee of Chiba University Hospital, and a written informed consent was obtained from all patients. The procedures used conformed to the tenets of the Declaration of Helsinki.
Participants
Twenty-one eyes of 12 patients who were diagnosed with NMOSD in the Department of Ophthalmology or Neurology of the Chiba University Hospital were studied (Table 1). A diagnosis of NMOSD was made by the 2015 International Consensus Diagnostic Criteria.[20] Nine of the 12 patients were seropositive for the anti-AQP4 antibody as determined by ELISA. Three anti-AQP4 seronegative patients were confirmed to be seronegative by cell-based assays, and the diagnosis of these patients was based on the presence of acute brainstem syndrome and the area postrema syndrome. The oligo clonal band (OCB) was majored in 10 of the 12 patients, and the samples were tested by isoelectric focusing and silver staining. None of the eyes had a history of optic neuritis.
Nineteen eyes of 10 volunteers recruited from the Chiba University staff were studied as healthy controls. The history and medical records of all the patients were reviewed to determine co-morbidities and history of optic neuritis.
The exclusion criteria were; history of optic neuritis as determined by examination of the medical records, presence of peripapillary RNFL thinning determined by OCT, myopia higher than -6 diopters, and the presence of glaucoma, cataract, and other retinal diseases. Slit-lamp examinations were performed to exclude obvious ophthalmological disease in our patients.
Ophthalmological examinations
The best-corrected visual acuity (BCVA) was monocularly measured in all participants using a retro-illuminated Landolt C chart, and the decimal BCVA was converted to the logarithm of the minimal angle of resolution (logMAR) units. The refractive error (spherical equivalent) was measured by a well-trained examiner.
Optical coherence tomography (OCT)
OCT was performed with the RS-3000 Advance (Nidek Corp, Tokyo, Japan) with software version 1.5.0. The RS-3000 is a spectral domain optical coherence tomographic instrument equipped with a confocal scanning laser ophthalmoscope. The RS-3000 scans consisted of 53 000 A-scans/sec and a 4 μm axial resolution which results in a clear differentiation of the different retinal layers (Fig 1A). The optic disc circle mode was used for circular scans around the optic disc to evaluate the peripapillary RNFL thickness (Fig 1B). The macula map mode was used for raster scanning over a 9 mm x 9 mm area centered on the fovea with a scan density of 512 horizontal A-scans. The data obtained from 9 mm radius of the foveal center was used to evaluate the thicknesses of the ganglion cell and inner plexiform layer (GCIP), the inner nuclear layer and outer plexiform layer (INL+OPL), and the ONL (Fig 1C). In addition, the average macular thickness (AMT) within a 3 mm radius of the foveal center was evaluated. The OCT images were recorded without pupillary dilatation by a well-trained examiner. The scans were assessed for the signal strength index (SSI), and images with SSI greater than 50 were analyzed. Scans with non-centered images or poorly colored thickness maps were excluded.
(A) Orange segmentation lines define the ganglion cell layer and inner plexiform layer (GCIP), the inner nuclear layer and outer plexiform layer (INL+OPL), and the outer nuclear layer (ONL). (B) Disc circle mode of OCT was used to evaluate the peripapillary retinal nerve fiber layer thickness around the optic disc. (C) Macula map mode was used to evaluate the thickness of the different retinal layers including the GCIP, INL+OPL, and ONL within a 9 mm x 9 mm area centered on the fovea.
Exclusion of eyes with peripapillary RNFL thinning
Eyes with peripapillary RNFL thinning were excluded to prevent the confounding effects of retrograde degeneration as has been described.[21] The OCT software used a computerized algorithm to compare the average peripapillary RNFL thickness of each participant with an embedded normative database of age-matched control subjects (ages ≥18 years). This algorithm assigned the measurements as a rank against a normal distribution percentile scheme derived from the database of age-matched controls. The measurements were separated into; normal (5–95th percentile), below normal (<5th percentile), markedly below normal (<1st percentile), or supra-normal (>95th percentile). The internal Nidek RS-3000 normative database consisted of 130 Asian subjects with a mean age of 47.6 ± 15.0 years.[22] Eyes that belonged to groups other than the normal were excluded.
Optical coherence tomographic segmentation
Automatic measurements of the thicknesses of the intraretinal layers including the peripapillary RNFL, GCIP, and ONL were made, and significance maps were determined by an in-built software of the RS3000. The RNFL thickness was measured between the internal limiting membrane and the outer boundary of the retinal nerve fiber layer. The GCIP thickness was measured between inner boundary of ganglion cell layer and the outer boundary of the inner plexiform layer (IPL). The INL+OPL thickness was measured between inner boundary of inner nuclear layer and the outer boundary of the outer plexiform layer. The ONL thickness was measured between the inner and outer boundary of the outer nuclear layer. Another measure obtained from optical coherence tomography scans centered on the foveal center was the average macular thickness (AMT). The AMT represents the thickness of the retina between the internal limiting membrane and the junction between the inner segments and outer segments of the photoreceptors within a 3 mm radius of the fovea.
Retinal sensitivity
Earlier studies have reported subclinical changes of the visual functions, e.g., reduced sensitivity for low contrast letters[13] and prolonged implicit times of the visually evoked potentials in eyes with NMOSD.[19] We determined the retinal sensitivity of the central 37 points or 10° by macular integrity assessment (MAIA: Topcon Corp, Tokyo, Japan). The MAIA microperimeter is a relatively new instrument equipped with a scanning laser ophthalmoscope with an eye tracking system.[23] MAIA has been used to determine the central retinal sensitivities of eyes with glaucoma,[24] age-related macular degeneration (AMD).[25] macular hole,[26] and other ophthalmic diseases. We selected to use MAIA because standard automated perimetry (SAP) cannot detect the visual dysfunction in eyes with peripapillary RNFL thinning[27], and MAIA microperimetry has been proven to be more sensitive than SAP.[28] The MAIA microperimeter measures the retinal sensitivity for a 37 sector grid covering 10° of the central retina, a 24 sector stimulus grid covering 10° to 2° around the central retina, and a 13 sector stimulus grid covering 2° of the central retina (Fig 2). The fixation target was a red circle of 1° diameter, the stimulus size was Goldmann III, the dynamic range of the stimulus was 36 dB, the background luminance was 4 apostilb (asb), and the maximum luminance was 1000 asb.
The retinal sensitivities were obtained from 37 points within the central 10 degrees of the foveal center. The average retinal sensitivity of the central 10°, central 10° to 2°, and central 2° were calculated. The macular integrity assessment (MAIA) was used to determine the retinal sensitivity. (A) Retinal sensitivity of a healthy control eye. Retinal sensitivities obtained from each point are shown on the left. The average sensitivity of central 10° and the histogram of threshold frequencies compared with built-in database of normal population are shown on the right. (B) Retinal sensitivity of an eye with neuromyelitis optica spectrum disorder (NMOSD). The patient was a 66-year-old woman who had history of longitudinally extensive transverse myelitis and was positive for serum autoantibody against aquaporin-4. The average retinal sensitivity of the central 10° was 27.0 dB whereas the average sensitivity of healthy control eyes was 29.39 dB.
Statistical analyses
All statistical analyses were performed using the R statistical software platform (version 3.2.4)[29]. General estimating equation models were used to determine if the differences of the data between the groups were statistically significant. Mann-Whitney U-tests were also used to determine if the differences in the ages between the groups were statistically significant. Multiple linear regression analysis was carried out to identify the intraretinal layers contributing to average macular thickness. Pearson’s correlation was used to determine the correlation between retinal sensitivity and ONL thickness. Pearson’s correlation was also used to determine the correlation between refractive error and retinal sensitivities. Statistical significance was defined as P <0.05
Results
The mean age of the patients with NMOSD was 49.5 ± 8.9 years and that of the controls was 53.2 ± 5.0 years (P = 0.07). The mean refractive error was -1.4 ± 2.1 diopters in the eyes with NMOSD and -0.6 ± 1.4 diopters in the controls (P = 0.27). One eye from one patient was excluded from the study due to a thinning of the pRNFL.
The thicknesses of the retinal layers evaluated by OCT and the visual functions of the patients with NMOSD and controls are shown in Table 2. The mean GCIP thickness was 55.7 ± 5.1 μm in the eyes with NMOSD and 57.4 ± 4.3 μm in the eyes of the controls (P = 0.28). The mean INL+OPL thickness was 63.7 ± 5.5 μm in the eyes with NMOSD and 63.3 ± 3.0 μm in the eyes of the controls (P = 0.78). The mean ONL thickness was 54.6 ± 5.1 μm in the eyes with NMOSD which was significantly thinner than that in the eyes of the controls at 59.8 ± 6.2 μm (P = 0.022). The mean AMT was 239.1 ± 17.5 μm in the eyes with NMOSD and 249.9 ± 8.9 μm in the controls. The AMT was significantly thinner in the NMOSD group than in control group (P = 0.036) (Fig 3).
The boxplot and the overlaid beeswarm plot showing the results of retinal sensitivity (RS) and optical coherence tomography (OCT) evaluation obtained from neuromyelitis optica spectrum disorder (NMO) group and healthy control (HC) group. (A) The result of retinal sensitivity (RS) of the central 10° area of retina. (B) The result of RS of the area between central 10° and 2° of the retina. (C) The result of RS evaluated from central 2°. (D), (E) The result of outer nuclear layer (ONL) thickness and average macular thickenss (AMT), respectively. *P <0.05.
We performed multiple regression analyses to identify the most contributing intra-retinal layer thickness to the AMT, and there was no significant difference in the contributions among layers. (see S1 Table).
The mean BCVA was 0.06 ± 0.04 logMAR units in the eyes with NMOSD and 0.09 ± 0.07 logMAR units in the controls (P = 0.19). The average retinal sensitivity of the central 10° in the eyes with NMOSD was 28.2 ± 1.8 dB which was significantly lower than that in the control group at 29.4 ± 0.7 dB (P = 0.013). The average retinal sensitivity in the 10° to 2° area was 28.0 ± 1.8 dB in the NMOSD group which was significantly lower than the 29.1 ± 0.7 dB in the control group (P = 0.022). The average retinal sensitivity in the central 2° was 28.1 ± 1.9 dB in the NMOSD group which was significantly lower than the 29.7 ± 1.1 dB in the control group (P = 0.002). The correlation between retinal sensitivity and ONL thickness was analyzed, but no significant correlation was observed. (see S2 Table) The correlation between refractive error and retinal sensitivity was also not significant. (see S3 Table)
Discussion
Our results showed that the ONL and AMT were significantly thinner in eyes with NMOSD than in the control eyes. On the other hand, the thicknesses of the GCIP and INL+OPL in eyes with NMOSD did not differ significantly from that of the control eyes. In addition, our results showed that the retinal sensitivity of the central 10°, 10° to 2°, and 2° were significantly lower in eyes with NMOSD than in the control eyes.
Our findings showed that the ONL was thinner in eyes with NMOSD without prior ON which is evidence that the morphological and sensitivity changes were due to a primary retinal pathology independent of retrograde degeneration.
A thinning of the ONL has been reported in patients with MS and NMOSD. For MS, Saidha et al reported a thinning of the inner nuclear layer (INL) and ONL in eyes without peripapillary RNFL thinning.[21] They suggested that the morphological changes were due to a primary retinal pathology.[21] For NMOSD, Syc et al[17] suggested that the ONL thinning resulted from an inflammation of the Müller cells secondary to a direct attack on Müller cells by anti-AQP4 antibody. On the other hand, Sotirchos et al [13] suggested that the ONL thinning in NMOSD resulted from subclinical optic neuropathy. The thinning of the peripapillary RNFL and GCIP in NMOSD can possibly be caused by an involvement of the anterior visual pathway. Therefore, the cause of the ONL thinning cannot be definitively determined by the findings of these earlier studies.
The difference of the present study from previous NMOSD studies is that we eliminated the effects of retrograde degeneration by excluding patients with reduced peripapillary RNFL thickness. Monteiro et al reported a thinning of the peripapillary RNFL in eyes with NMOSD without prior ON, and it was assumed to be the result of subclinical axonal loss suggesting an involvement of the anterior visual pathway. Because the confounding effect of retrograde degeneration was excluded in the present study, our results indicate that the ONL thinning was most likely independent of any retrograde degeneration.
To identify the factors contributing to the thinning of the AMT, we performed multiple regression analyses of all of the intraretinal layers. The analyses were based on the data of either the right or left eyes to avoid intra-subject and inter-eye dependencies. However, the results of the analyses showed no significant contribution of any retinal layer. (see S1 Table) We believe that the low sample size might have prevented the results from attaining statistical significance.
The microperimetric results showed a reduction of central retinal sensitivities. These findings support the results of an earlier study that reported a reduction of the visual acuity for low contrast letters in eyes with NMOSD without prior optic neuritis.[13] A prolongation of the implicit times of the visual evoked potential in eyes with NMOSD without a prior optic neuritis has been reported,[19] and this would suggest an involvement of the anterior visual pathway in patients with no history of optic neuritis. Because retrograde degeneration was excluded from our study, we believe that the reduced retinal sensitivity was most likely not due to retrograde degeneration. The results also indicate that microperimetry is useful for detecting subclinical impairments of visual function because conventional visual acuity measurements may not detect a reduction of the BCVA.
In the seronegative NMOSD patients of the present study, the antibody might not be detected leaving the possibility of antibody existing in these patients. Jiao et al[30] reported that the sensitivity of serological status of NMOSD varies between the assays, and the most sensitive assay was reported to be fluorescence-activated cell sorting assay which we did not conduct. Zajda et al[31] have also reported that seronegative NMOSD patients had lower levels of serum aquaporin 4 concentration than multiple sclerosis and control group, suggesting that serum anti-aquaporin 4 can be used as a diagnostic marker of NMOSD. These new techniques should be used in future studies to ensure an accurate serological status of the subjects.
Previous study have reported that anti-myelin oligodendrocyte glycoprotein (MOG) antibody is detected in subgroup of seronegative NMOSD[32]. The course of the disease is reported to be favorable in NMOSD patients with positive MOG antibody[33], but whether the subgroup can be categorized as a distinct disease from NMOSD remains to be determined[34]. In the preset study, seronegative NMOSD patients might be related to anti-MOG antibody, but we did not test for anti-MOG antibody. Future studies should include the test for this increasingly recognized antibody.
The results of earlier studies showed that low to moderate myopia can affect the results of retinal sensitivity measurements. Gella et al [35] have reported that the retinal sensitivity is positively correlated with the refractive error. In the present study, the difference in the refractive errors between NMOSD and HC group was not significant. This then allowed a comparison of the data between the two groups. In addition, the correlations between the refractive error and the retinal sensitivity were also not significant (see S3 Table). Thus, we suggest that the effect of the refractive error was minimal in our patients.
The thickness of the ONL has been reported to be significantly correlated with different visual functions,[36] but we did not confirm the correlation between retinal sensitivities and ONL thickness. (see S2 Table) This result may be due to low sample size, and the larger sample is needed in future studies to reconfirm the function-morphological correlation.
The exact mechanism causing the primary retinal pathology was not determined, but previous reports suggested that the retinal pathology of NMOSD was related to the Müller cells. [11, 21] AQP4 is a water channel mainly expressed on the foot processes of astrocytes in the central nervous system,[3, 37] Pathological studies have shown that astrocytes were preferentially targeted in eyes with NMOSD.[38] In the retina, Müller cells are the major astrocytes, and it has been shown that AQP4 is expressed on human Müller cells.[39] These findings led to the hypothesis that retinal Müller cells are directly attacked by anti-AQP4 antibody.
Müller cells are specialized glial cells which span the entire thickness of the retina.[40] The main functions of Müller cells are maintaining the ion and water homeostasis of the retina and providing metabolic support and nutrition to the retinal neurons.[40]
Once Müller cells are attacked by anti-AQP4 antibodies, it is possible that retinal neurons would undergo secondary damage which would then result in the loss of neurons. Any neurons in retina could suffer from Müller cell dysfunction because Müller cells span the entire thickness of retina. However, we excluded eyes with inner retinal layer thinning to focus on changes of the outer retinal layers including the ONL. To evaluate the effect of primary retinal pathology on the inner retinal layers, pathological studies on animal models of NMOSD are essential.
For the anti-AQP4 antibody to attack Müller cells, the antibody must have access to the Müller cells. Although vascular abnormalities including retinal artery attenuation have been reported in eyes with NMO,[41] leakage from the retinal vessels has not been demonstrated.[41] The blood-brain barrier has been reported to be compromised in eyes with NMOSD,[42] and we suggest that the blood-retinal barrier might also be compromised giving access of anti-AQP4 antibody to the retinal tissues.
Thus, our results suggest that the alterations of retinas in eyes with NMOSD are due to a primary retinal pathology. In a previous study, the thinning of the inner retinal layer in eyes with MS and NMOSD was explained by retrograde degeneration due to optic neuritis or subclinical optic neuritis.[13] The results of our study suggest a pathology independent of retrograde degeneration, and the results suggest a primary retinal pathology including a direct attack of the retina by anti-AQP4 antibody (Fig 4).
(A) In retrograde degeneration of neuromyelitis optica spectrum disorder (NMOSD), involvement of anterior visual pathway results in a thinning of the inner retinal layers including the retinal nerve fiber layer(RNFL) and ganglion cell-inner plexiform layer (GCIP). (B) In direct retinal pathology of NMOSD, a direct attack of Müller cells by anti-aquaporin 4 (AQP4) antibody results in a secondary loss of retinal neurons including ONL thinning.
Our study has several limitations. First, the number of NMOSD patients was small. The small population size limited the strength of the statistical analysis and the likelihood of reaching the statistical significant threshold. A study with a larger cohort is needed to confirm the results of this study.
Second, lack of angiographic data prevented a confirmation of leakage from the retinal vessels and the access of anti-AQP4 antibody to retinal tissue. Future studies are needed to evaluate the integrity of the blood-retinal barrier and the retinal vascular system.
Third, there was a lack of pathological examinations of eyes with NMOSD. Future studies are needed to include pathological examinations to confirm the existence of anti-AQP4 antibody in the retinal tissues and morphological changes of the retina.
Fourth, the results have a limitation due to the evaluation method. Oberwahrenbrock et al and Otani et al reported that the ONL thickness might be underestimated by the high reflection of Henle’s fiber in outer plexiform layer. [43, 44] Lujan et al also reported that the ONL thickness measurements were affected by the beam angle of the OCT due to the existence of Henle fiber layer, and also that directional OCT is needed for accurate measurements. [45] Because our method was not designed to control the incidence of the OCT beam, caution is needed in interpreting our data on the ONL.
Finally, we were not able to conclude that anti-AQP4 antibodies were directly attacking the retina in eyes with NMOSD, and histopathological examinations would enable confirming our hypothesis.
In conclusion, our results showed that the retinal sensitivity was significantly reduced along with a significant thinning of the ONL in eyes with NMOSD without prior optic neuritis. We suggest that the cause of ONL thinning is a primary retinal pathology, and the decreased retinal sensitivity might be secondary to the ONL thinning.
Supporting Information
S1 Table. Results of multiple regression analyses of different retinal layers contributing to the average macular thickness.
https://doi.org/10.1371/journal.pone.0167473.s001
(DOCX)
S2 Table. Correlations between retinal sensitivities and outer nuclear layer thickness.
https://doi.org/10.1371/journal.pone.0167473.s002
(DOCX)
S3 Table. Correlation between refractive error and retinal sensitivities.
https://doi.org/10.1371/journal.pone.0167473.s003
(DOCX)
Acknowledgments
The authors thank Toshiyuki Takahashi, Tohoku University Graduate School of Medicine, for serological assays.
Author Contributions
- Conceptualization: RA HY MM SK.
- Data curation: RA HY TO.
- Formal analysis: RA HY MM.
- Investigation: TO TB.
- Methodology: TB SS.
- Project administration: SK SY.
- Resources: MM SS SK.
- Software: RA HY.
- Supervision: SK SY.
- Validation: TB.
- Visualization: RA HY.
- Writing – original draft: RA.
- Writing – review & editing: HY MM SK SY.
References
- 1. Wingerchuk DM, Hogancamp WF, O'Brien PC, Weinshenker BG. The clinical course of neuromyelitis optica (Devic's syndrome). Neurology. 1999;53(5):1107–14. pmid:10496275
- 2. Lennon VA, Wingerchuk DM, Kryzer TJ, Pittock SJ, Lucchinetti CF, Fujihara K, et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet. 2004;364(9451):2106–12. pmid:15589308
- 3. Lennon VA, Kryzer TJ, Pittock SJ, Verkman AS, Hinson SR. IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. The Journal of experimental medicine. 2005;202(4):473–7. pmid:16087714
- 4. Wingerchuk DM, Lennon VA, Lucchinetti CF, Pittock SJ, Weinshenker BG. The spectrum of neuromyelitis optica. The Lancet Neurology. 2007;6(9):805–15. pmid:17706564
- 5. Petzold A, de Boer JF, Schippling S, Vermersch P, Kardon R, Green A, et al. Optical coherence tomography in multiple sclerosis: a systematic review and meta-analysis. The Lancet Neurology. 2010;9(9):921–32. Epub 2010/08/21. pmid:20723847
- 6. Naismith RT, Tutlam NT, Xu J, Klawiter EC, Shepherd J, Trinkaus K, et al. Optical coherence tomography differs in neuromyelitis optica compared with multiple sclerosis. Neurology. 2009;72(12):1077–82. pmid:19307541
- 7. Narayanan D, Cheng H, Bonem KN, Saenz R, Tang RA, Frishman LJ. Tracking changes over time in retinal nerve fiber layer and ganglion cell-inner plexiform layer thickness in multiple sclerosis. Multiple sclerosis. 2014;20(10):1331–41. pmid:24639478
- 8. Garcia-Martin E, Polo V, Larrosa JM, Marques ML, Herrero R, Martin J, et al. Retinal layer segmentation in patients with multiple sclerosis using spectral domain optical coherence tomography. Ophthalmology. 2014;121(2):573–9. Epub 2013/11/26. pmid:24268855
- 9. Merle H, Olindo S, Donnio A, Richer R, Smadja D, Cabre P. Retinal peripapillary nerve fiber layer thickness in neuromyelitis optica. Investigative ophthalmology & visual science. 2008;49(10):4412–7.
- 10. Ratchford JN, Quigg ME, Conger A, Frohman T, Frohman E, Balcer LJ, et al. Optical coherence tomography helps differentiate neuromyelitis optica and MS optic neuropathies. Neurology. 2009;73(4):302–8. pmid:19636050
- 11. Outteryck O, Majed B, Defoort-Dhellemmes S, Vermersch P, Zephir H. A comparative optical coherence tomography study in neuromyelitis optica spectrum disorder and multiple sclerosis. Multiple sclerosis. 2015.
- 12. Fernandes DB, Raza AS, Nogueira RG, Wang D, Callegaro D, Hood DC, et al. Evaluation of inner retinal layers in patients with multiple sclerosis or neuromyelitis optica using optical coherence tomography. Ophthalmology. 2013;120(2):387–94. pmid:23084127
- 13. Sotirchos ES, Saidha S, Byraiah G, Mealy MA, Ibrahim MA, Sepah YJ, et al. In vivo identification of morphologic retinal abnormalities in neuromyelitis optica. Neurology. 2013;80(15):1406–14. Epub 2013/03/22. pmid:23516321
- 14. de Seze J, Blanc F, Jeanjean L, Zephir H, Labauge P, Bouyon M, et al. Optical coherence tomography in neuromyelitis optica. Archives of neurology. 2008;65(7):920–3. pmid:18625858
- 15. Schneider E, Zimmermann H, Oberwahrenbrock T, Kaufhold F, Kadas EM, Petzold A, et al. Optical Coherence Tomography Reveals Distinct Patterns of Retinal Damage in Neuromyelitis Optica and Multiple Sclerosis. PloS one. 2013;8(6):e66151. Epub 2013/06/28. pmid:23805202
- 16. Lange AP, Sadjadi R, Zhu F, Alkabie S, Costello F, Traboulsee AL. Spectral-domain optical coherence tomography of retinal nerve fiber layer thickness in NMO patients. Journal of neuro-ophthalmology: the official journal of the North American Neuro-Ophthalmology Society. 2013;33(3):213–9. Epub 2013/07/19.
- 17. Syc SB, Saidha S, Newsome SD, Ratchford JN, Levy M, Ford E, et al. Optical coherence tomography segmentation reveals ganglion cell layer pathology after optic neuritis. Brain: a journal of neurology. 2012;135(Pt 2):521–33.
- 18. Park KA, Kim J, Oh SY. Analysis of spectral domain optical coherence tomography measurements in optic neuritis: differences in neuromyelitis optica, multiple sclerosis, isolated optic neuritis and normal healthy controls. Acta ophthalmologica. 2014;92(1):e57–65. pmid:23889747
- 19. Ringelstein M, Kleiter I, Ayzenberg I, Borisow N, Paul F, Ruprecht K, et al. Visual evoked potentials in neuromyelitis optica and its spectrum disorders. Multiple sclerosis. 2014;20(5):617–20. pmid:24009163
- 20. Wingerchuk DM, Banwell B, Bennett JL, Cabre P, Carroll W, Chitnis T, et al. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology. 2015;85(2):177–89. pmid:26092914
- 21. Saidha S, Syc SB, Ibrahim MA, Eckstein C, Warner CV, Farrell SK, et al. Primary retinal pathology in multiple sclerosis as detected by optical coherence tomography. Brain: a journal of neurology. 2011;134(Pt 2):518–33.
- 22.
Normative database of RS-3000, Nidec corp, 2010
- 23. Markowitz SN, Reyes SV. Microperimetry and clinical practice: an evidence-based review. Canadian journal of ophthalmology Journal canadien d'ophtalmologie. 2013;48(5):350–7. pmid:24093179
- 24. Ozturk F, Yavas GF, Kusbeci T, Ermis SS. A comparison among Humphrey field analyzer, Microperimetry, and Heidelberg Retina Tomograph in the evaluation of macula in primary open angle glaucoma. Journal of glaucoma. 2008;17(2):118–21. pmid:18344757
- 25. Alexander P, Mushtaq F, Osmond C, Amoaku W. Microperimetric changes in neovascular age-related macular degeneration treated with ranibizumab. Eye. 2012;26(5):678–83. pmid:22322998
- 26. Hasler PW, Prunte C. Early foveal recovery after macular hole surgery. The British journal of ophthalmology. 2008;92(5):645–9. pmid:18296507
- 27. Noval S, Contreras I, Rebolleda G, Munoz-Negrete FJ. Optical coherence tomography versus automated perimetry for follow-up of optic neuritis. Acta ophthalmologica Scandinavica. 2006;84(6):790–4. pmid:17083540
- 28. Lima VC, Prata TS, De Moraes CG, Kim J, Seiple W, Rosen RB, et al. A comparison between microperimetry and standard achromatic perimetry of the central visual field in eyes with glaucomatous paracentral visual-field defects. The British journal of ophthalmology. 2010;94(1):64–7. pmid:19692366
- 29. Ihaka R, Gentleman R. R: A Language for Data Analysis and Graphics. Journal of Computational and Graphical Statistics. 1995;5(3):299–314.
- 30. Jiao Y, Fryer JP, Lennon VA, Jenkins SM, Quek AM, Smith CY, et al. Updated estimate of AQP4-IgG serostatus and disability outcome in neuromyelitis optica. Neurology. 2013;81(14):1197–204. pmid:23997151
- 31. Zajda M, Kazmierczak B, Zakrzewska-Pniewska B. Aquaporin-4: A novel diagnostic biomarker for seronegative neuromyelitis optica. Multiple sclerosis. 2015.
- 32. Kitley J, Woodhall M, Waters P, Leite MI, Devenney E, Craig J, et al. Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype. Neurology. 2012;79(12):1273–7. pmid:22914827
- 33. Sato DK, Callegaro D, Lana-Peixoto MA, Waters PJ, de Haidar Jorge FM, Takahashi T, et al. Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders. Neurology. 2014;82(6):474–81. Epub 2014/01/15. pmid:24415568
- 34. Zamvil SS, Slavin AJ. Does MOG Ig-positive AQP4-seronegative opticospinal inflammatory disease justify a diagnosis of NMO spectrum disorder? Neurology(R) neuroimmunology & neuroinflammation. 2015;2(1):e62.
- 35. Gella L, Raman R, Sharma T. Evaluation of in vivo human retinal morphology and function in myopes. Current eye research. 2011;36(10):943–6. pmid:21950700
- 36. Matsumoto H, Sato T, Kishi S. Outer nuclear layer thickness at the fovea determines visual outcomes in resolved central serous chorioretinopathy. American journal of ophthalmology. 2009;148(1):105–10 e1. pmid:19327740
- 37. Nielsen S, Nagelhus EA, Amiry-Moghaddam M, Bourque C, Agre P, Ottersen OP. Specialized membrane domains for water transport in glial cells: high-resolution immunogold cytochemistry of aquaporin-4 in rat brain. The Journal of neuroscience: the official journal of the Society for Neuroscience. 1997;17(1):171–80.
- 38. Misu T, Fujihara K, Kakita A, Konno H, Nakamura M, Watanabe S, et al. Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis. Brain: a journal of neurology. 2007;130(Pt 5):1224–34.
- 39. Nagelhus EA, Veruki ML, Torp R, Haug FM, Laake JH, Nielsen S, et al. Aquaporin-4 water channel protein in the rat retina and optic nerve: polarized expression in Muller cells and fibrous astrocytes. The Journal of neuroscience: the official journal of the Society for Neuroscience. 1998;18(7):2506–19.
- 40. Bringmann A, Pannicke T, Grosche J, Francke M, Wiedemann P, Skatchkov SN, et al. Muller cells in the healthy and diseased retina. Progress in retinal and eye research. 2006;25(4):397–424. pmid:16839797
- 41. Green AJ, Cree BA. Distinctive retinal nerve fibre layer and vascular changes in neuromyelitis optica following optic neuritis. Journal of neurology, neurosurgery, and psychiatry. 2009;80(9):1002–5. pmid:19465415
- 42. Tomizawa Y, Yokoyama K, Saiki S, Takahashi T, Matsuoka J, Hattori N. Blood-brain barrier disruption is more severe in neuromyelitis optica than in multiple sclerosis and correlates with clinical disability. The Journal of international medical research. 2012;40(4):1483–91. pmid:22971500
- 43. Oberwahrenbrock T, Weinhold M, Mikolajczak J, Zimmermann H, Paul F, Beckers I, et al. Reliability of Intra-Retinal Layer Thickness Estimates. PloS one. 2015;10(9):e0137316. pmid:26349053
- 44. Otani T, Yamaguchi Y, Kishi S. Improved visualization of Henle fiber layer by changing the measurement beam angle on optical coherence tomography. Retina. 2011;31(3):497–501. pmid:21102368
- 45. Lujan BJ, Roorda A, Croskrey JA, Dubis AM, Cooper RF, Bayabo JK, et al. Directional Optical Coherence Tomography Provides Accurate Outer Nuclear Layer and Henle Fiber Layer Measurements. Retina. 2015;35(8):1511–20. pmid:25829348